Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:
- an article about two recent rulings by the Federal Circuit that may “dent the number of Section 101 motions to dismiss that courts fully or partially grant each year”;
- another article about a Federal Circuit case that would “clear the way for a proposed generic” opioid drug; and
- a blog post about a decision in which the Federal Circuit held “the definition of a claim term in a patent incorporated by reference into the patents at issue does not dictate the definition of claims in the asserted patents.”